A 57-year-old woman undergoes treatment with chemotherapy for a recently diagnosed ovarian cancer. Her physician added mensa to her chemotherapeutic agents.
Which of these risks can be avoided by this new prescription?
A- Severe nausea and vomiting
B- Hair loss
C- Hemorrhagic cystitis
D- Iron deficiency anemia
E- Hepatic cyst
This patient is taking cyclophosphamide. Hemorrhagic cystitis is a common side effect to this chemotherapeutic agent. Mensa is used in combination with cyclophosphamide to prevent the development of hemorrhagic cystitis and transitional cell carcinoma.
The correct answer is C